HLS
Healius Ltd
Healthcare Providers and Services
·
Healthcare
13
comments
6
fund managers
past 90 days
About Healius Ltd
Healius Ltd. is a Sydney-based healthcare company founded in 1985 by Edmund Gregory Thomas Bateman. The company provides healthcare technology and diagnostic services, operating through three primary segments: Pathology, Imaging, and Other. The Pathology segment delivers pathology services, while the Imaging segment provides diagnostic imaging through stand-alone sites, hospitals, and medical centers. The Other segment encompasses the company’s corporate support functions. Healius focuses on integrated healthcare delivery systems to support patient outcomes across Australia.
Commentary Volume
13
Comments
6
Fund managers
0
Past 90 days
SOURCE
ACTION
COMMENT PREVIEW
FUND MANAGER
DATE
Loading...
.
Loading...
Loading...
Loading...
Loading...
Source: Ipsum Capital Q4 Quarterly Letter · Published 14 March 2025
Report a problem
Loading...
.
Loading...
Loading...
Loading...
Loading...
§ Important Notice
The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Commentary
Sector
Healthcare
Market cap
$247M
Fund managers
6 managers
First covered
30 June 2024
Last updated
30 Apr 2026
Company Details
Related Themes
ic
Ipsum Capital
6 comments
ic
Amet Funds
4 comments
ic
Dolor
3 comments
Top Investors Covering MIN
§ Reminder
The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Frequently asked questions about Healius Ltd (ASX:HLS)
Frequently asked questions
Who is investing in Healius Ltd (ASX:HLS)?
Fund managers including Spheria Asset Management, Perpetual Asset Management, Tamim Funds Management, Wentworth Williamson, Blackwattle Investment Partners and Ellerston Capital have invested in Healius Ltd (ASX:HLS).
What is the short interest in Healius Ltd (ASX:HLS)?
The short interest in Healius Ltd (ASX:HLS) is 3.94% which makes it the 59th most shorted stock on the ASX. Of the 726.1M shares that Healius Ltd has on issue, 28.6M have been sold short.
What does Healius Ltd (ASX:HLS) do?
Healius Ltd. is a Sydney-based healthcare company founded in 1985 by Edmund Gregory Thomas Bateman. The company provides healthcare technology and diagnostic services, operating through three primary segments: Pathology, Imaging, and Other. The Pathology segment delivers pathology services, while the Imaging segment provides diagnostic imaging through stand-alone sites, hospitals, and medical centers. The Other segment encompasses the company’s corporate support functions. Healius focuses on integrated healthcare delivery systems to support patient outcomes across Australia.
Loading...